WADA's Peptide Ban List: What Canadian Athletes Need to Know

The Blanket Ban: Understanding S0

The most important thing Canadian athletes need to understand about peptides and anti-doping regulations is the S0 category. WADA's Prohibited List includes a catch-all section — S0: Non-Approved Substances — that states:

"Any pharmacological substance which is not addressed by any of the subsequent sections of the List and with no current approval by any governmental regulatory health authority for human therapeutic use is prohibited at all times."

This single sentence effectively bans virtually every research peptide, including those not specifically named elsewhere on the list. Because research peptides are, by definition, not approved for human therapeutic use by Health Canada (or any other regulatory authority), they fall automatically under S0.

Specifically Named Peptides

Beyond the S0 catch-all, several peptide categories are specifically named on the Prohibited List:

S2: Peptide Hormones, Growth Factors, and Related Substances - **Growth Hormone Releasing Hormones (GHRHs):** [CJC-1295](/peptides/cjc-1295), Sermorelin, Tesamorelin - **Growth Hormone Secretagogues (GHSs):** [Ipamorelin](/peptides/ipamorelin), Hexarelin, GHRP-2, GHRP-6, MK-677 - **Growth Hormone fragments:** AOD-9604 - **GLP-1 receptor agonists:** Semaglutide (when used without a valid medical prescription)

S4: Hormone and Metabolic Modulators - **Selective androgen receptor modulators (SARMs)** — not peptides but often sold alongside them

S0: Non-Approved Substances (blanket category) - BPC-157 - TB-500 (Thymosin Beta-4) - Melanotan II - PT-141 (note: bremelanotide/Vyleesi has FDA approval but not universal regulatory approval) - DSIP - Selank - Epithalon - Thymosin Alpha-1 (has limited approvals in some countries but not in Canada)

How Testing Works

Modern anti-doping testing for peptides uses liquid chromatography-tandem mass spectrometry (LC-MS/MS), which can detect peptide metabolites at extremely low concentrations (picogram to nanogram levels).

Key points about peptide testing:

• Detection windows vary widely. Some peptides can be detected for days after a single dose; others have windows of only hours.
• Metabolite detection is increasingly used. Even if the parent peptide is cleared quickly, metabolic byproducts may persist longer.
• Testing methodology improves annually. Detection windows that were hours in 2020 may be days or weeks with current techniques.
• Dried blood spot (DBS) testing is being implemented, allowing for easier sample collection and potentially longer detection windows for some analytes.

The Canadian Context: CCES Enforcement

In Canada, anti-doping enforcement is handled by the Canadian Centre for Ethics in Sport (CCES), which implements the Canadian Anti-Doping Program under the WADA Code. CCES conducts both in-competition and out-of-competition testing for athletes in the Canadian Anti-Doping Program registered testing pool.

Key considerations for Canadian athletes:

• Strict liability applies. Athletes are responsible for any substance found in their sample, regardless of how it got there. "I didn't know it contained a banned substance" is not a valid defence.
• Therapeutic Use Exemptions (TUEs) are available for medically necessary substances (like semaglutide prescribed for diabetes) but require advance application and approval.
• Supplement contamination is a real risk. Some supplements have been found to contain undeclared peptides. Athletes should use only supplements tested through programmes like NSF Certified for Sport or Informed Sport.
• The burden of proof for reduced sanctions falls on the athlete to demonstrate how the substance entered their body.

Practical Implications

• If you are a competitive athlete subject to CCES testing: Consider all research peptides prohibited. The S0 catch-all leaves no room for ambiguity.
• If you are a recreational athlete not subject to testing: The WADA list doesn't technically apply, but be aware that some sports organisations and fitness federations implement their own testing programmes.
• If you are a researcher working with athletic populations: Ensure study participants understand and consent to the implications of peptide administration for their competitive eligibility.

A Note on Prescription Peptides

Some peptides that appear on the Prohibited List are also available as prescription medications. Semaglutide (Ozempic, Wegovy) is a prime example. Athletes with a legitimate medical need can apply for a TUE, which, if approved, allows them to use the medication without violation.

However, the TUE process requires advance application, medical documentation, and approval by the relevant anti-doping authority. Retroactive TUEs are possible but significantly more complex.

For more on the broader regulatory landscape for peptides in Canada, see our peptide legality guide.